Log In
BCIQ
Print this Print this
 

MEDI-6469

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionMurine anti-OX40 mAb
Molecular Target OX40 ligand (OX40L) (CD134L)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/15/2012

Undisclosed

0

Undisclosed

Get a free BioCentury trial today